Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Elamipretide for Sale > 100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock
100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock buy - large image1
100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock buy - image1
100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock buy - image2
100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock buy - image3
100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock buy - image4
100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock buy - image5
100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock buy - image6

100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock

102 Inquiries

Unit Price: Get Latest Price
CAS No.:

736992-21-5

Grade:

Pharmaceutical Grade

Content:

100%

Port:

ningbo

Brand:

Maxshow

Packaging:

5mg 10mg 15mg 30mg per vial; 10vials/box

Sample Available:

Yes

Price valid (until):

2025-05-09

Company Type:
Trader
Location:
The British Virgin Islands
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  



    Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity. 

    Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.
    English name Thymalin
    Cas number 63958-90-7
    Synonyms
    pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn;
    STF, SeruM ThyMic Factor, ThyMulin;
    L-Asparagine,5-oxo-L-prolyl-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-;
    Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH trifluoroacetate salt;
    Serum thymic factor (porcine);
    Thymic serum factor;
    Thymic serum factor (pig);
    PYR-ALA-LYS-SER-GLN-GLY-GLY-SER-ASN
    Purity 99%


    Other hot selling products:


    Semaglutide is a new generation GLP-1 (glucagon-like peptide-1) analogues. Semaglutide is a long-acting dosage form based on the basic structure of liraglutide, which is more effective in the treatment of type 2 diabetes mellitus. Compared with lilarlutide, somalutide has a longer aliphobic chain and an increased hydrophobicity, but somalutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced.PEG modification can not only tightly bind to albumin, cover up the DPP-4 enzymatic hydrolysis site, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

    Molecular Weight: 4813.45

    Appearance: White Powder

    Purity (HPLC): ≥99.0%

    Single Impurity (HPLC): ≤1.0%

    Moisture Content (Karl Fischer): ≤10.0%

    Peptide Content: ≥80.0%

    Storage: Store at -20℃ degrees Celsius in a dry and cool place.

    Storage Condition: Store at -20°C Solubility in DMSO: 3mg/mL (0.73 mM)


    SEMAGLUTIDE & TIRZEPATIDE


    GLP-1 agonists were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes, but some have also been FDA approved to treat weight loss. The GLP-1 agonists we work with are called Semaglutide & Tirzepatide. 
    Tirzepatide is dosed at 5-15mg per week

    Semaglutide is dosed at 0.5-2.4mg per week

    Product Function:

    • Helps slow food leaving your stomach
    • Helps prevent your liver from making too much sugar
    • Helps the pancreas produce more insul when your blood sugar levels are high
    • Can help control blood glucose
    • Can reduce hyperglycemia, especially after meals
    • Can reduce fasting insul and fasting glucose
    • Can reduce hemoglobin A1c
    • Can decrease appetite and caloric intake, while inhibiting weight gain
    • Has been shown to lower triglyceride levels and oxidative stress from high LDL
    • Has been shown to help induce weight loss in obese patients with higher dosing
    • Helps decrease leptin and increase leptin sensitivity
    • Can increase the conversion of white fat to brown fat


    Shop 100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock-Detailed Image 1 Shop 100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock-Detailed Image 2 Shop 100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock-Detailed Image 3 Shop 100% high quality SS-31 CAS 736992-21-5 Lyophilized Powder Peptide in stock-Detailed Image 4



    ECHEMI Editorial Reference
    Elamipretide has been used in trials studying the treatment of Leber's Hereditary Optic Neuropathy.
    Elamipretide, also known as MTP 131, is a mitochondria-targeted peptide antioxidant. Elamipretide decreases inflammation and protect against a variety of neurological illnesses. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Elamipretide Promotes Mitophagosome Formation and Prevents Its Reduction Induced by Nutrient Excess in INS1 β-cells.
    Elamipretide Synthetic is a single, non-glycosylated polypeptide chain containing 4 amino acids, having a molecular mass of 640 Dalton and a Molecular formula of C32H49N9O5 .

    Basic Info
    Product Name:

    Elamipretide

    Other Name:

    D-Arginyl-2,6-diMethyl-L-tyrosyl-L-lysyl-L-phenylalaninaMide;Elamipretide;L-Phenylalaninamide, D-arginyl-2,6-dimethyl-L-tyrosyl-L-lysyl-;Elamipretide (TFA salt);SS-31;MTP-131;BENDAVIA;Bendavia);Elamipretide (SS-31;ELAMIPRETIDE, >99%

    CAS No.:

    736992-21-5

    Molecular Formula:

    C32H49N9O5

    InChIKeys:

    SFVLTCAESLKEHH-WKAQUBQDSA-N

    Molecular Weight:

    639.79

    Exact Mass:

    639.38566570

    EC Number:

    205-858-1

    UNII:

    87GWG91S09

    DSSTox ID:

    DTXSID50471988

    Color/Form:

    White to Off-White

    Characteristics
    Density:

    1.34±0.1 g/cm3(Predicted)

    PKA:

    10.10±0.25(Predicted)

    Research
    Class:

    Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)

    Status:

    FDA-approved (Forzinity) — Accelerated Approval 2025

    Mechanism:

    A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.

    Activity note:

    SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.

    Source:

    Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI

    Clinical Development:

    NCT03098797; NCT02814097; NCT02976038; NCT03354065

    FDA:

    Forzinity (approved 2025-09-19)

    References
    ChEMBL:

    CHEMBL3833370

    DrugBank:

    DB11981

    KEGG DRUG:

    D10925

    PubChem:

    PubChem

    Disclaimer:

    Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptides

    Location:

    BRITISH VIRGIN ISLANDS

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    11-50

    Year of Establishment:

    2024

  • Inquiry History
    102 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    SS-31 (Elamipretide MTP-131) CAS 736992-21-5 99% White Powder XO

    10  Oct 22, 2023
    United States

    SS-31

    500 MG Feb 20, 2026
    Philippines

    Elamipretide

    100 MG Mar 17, 2026
    Philippines

    Elamipretide / SS-31

    5 G Mar 16, 2026
    Kazakstan

    SS-31

    500 MG May 22, 2026
    Philippines

    SS-31

    30 MG Sep 15, 2026
    United States

    SS-31

    20 MG Aug 25, 2026
    United States

    SS31

    20 MG Aug 25, 2026
    United States

    Ss-31 Elamipretide

    1 PCS Aug 16, 2026
    Belgium

    Elamipretide SS-31

    50 MG Jun 18, 2026
    United States

    Elamipretide

    1 MG Jun 18, 2026
    United States

    Ss-31

    30 MG May 20, 2026
    United States

    SS-31

    50 MG May 19, 2026
    United States

    SS-31

    1 KG May 7, 2026
    United States

    SS-31 (elamipretide)

    450 MG May 3, 2026
    Russia

    SS-31 Elamipretide

    50 G Apr 3, 2026
    United States

    SS-31

    1 G Mar 30, 2026
    United States

    Elamipretide

    10 MT Mar 27, 2026
    United States

    ss31

    1 KG Mar 16, 2026
    Brazil

    SS 31 Elamipretide

    10 PCS Mar 5, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.